BRCA1-mutation carriers are diagnosed with ovarian cancer at a younger age (average age 52) compared to BRCA2-mutation carriers (age 62) and sporadic cases (age 63) [35]. The gene discussed is BRCA2; the disease is ovarian carcinoma.